CAN
ZSAN

Cetera Advisor Networks’s Zosano Pharma Corporation ZSAN Stock Holding History

Cetera Advisor Networks’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-31
Closed -$1K – 3295
2020
Q2 		$1K Buy
+31
New +$875 ﹤0.01% 3417

Other funds holding ZSAN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cetera Advisor Networks's ZSAN Position: Q3 2020 in Review

Cetera Advisor Networks sold out of Zosano Pharma Corporation (ZSAN) in Q3 2020, closing a stake of 31 shares — an estimated $1K sold.

Cetera Advisor Networks first reported a position in ZSAN in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 43 funds tracked by Wall St. Rank hold ZSAN as of Q3 2020.

  • Cetera Advisor Networks reported no remaining Zosano Pharma Corporation position as of Q3 2020 after selling out during the quarter.
  • Cetera Advisor Networks sold 31 Zosano Pharma Corporation shares in Q3 2020, an estimated $1K.
  • Cetera Advisor Networks first reported a position in Zosano Pharma Corporation in Q2 2020 and held it in 1 quarter.
  • Cetera Advisor Networks's Zosano Pharma Corporation position peaked at $1K in Q2 2020.
  • 43 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q3 2020.

Based on Cetera Advisor Networks's 13F filing for Q3 2020, filed 13 Nov 2020.